Cite

HARVARD Citation

    Komrokji, R. et al. (2018). Azacitidine in Lower‐Risk Myelodysplastic Syndromes: A Meta‐Analysis of Data from Prospective Studies. Oncologist. pp. 159-170. [Online]. 
  
Back to record